The Motley Fool

4 Super Stocks I’d Buy With £10,000

An investors’ total return is made up of capital gains and income. Most investors, of course, tend to focus on one or the other. However, there are companies out there that offer a potent mix of both income and the potential for capital gains. Here are four that do so and, as such, could be worth investing in.


GlaxoSmithKline’s (LSE: GSK) (NYSE: GSK.US) update this week showed that the company continues to struggle from the effects of generic competition, while its share price has been subdued at least partly because of bribery allegations in China. However, GlaxoSmithKline has vast potential, with the company having an enviable pipeline of drugs that should propel earnings numbers upwards over the long run. Having sold off consumer brands such as Lucozade and Ribena, the company is now free to focus on drug development and, with shares trading on a price to earnings (P/E) ratio of just 13.1, they offer good value at current levels. Meanwhile, a yield of 5.5% is highly attractive and is well above the FTSE 100’s yield of 3.4%.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...


HSBC (LSE: HSBA) continues to offer investors top-notch income and growth potential. Indeed, the bank is forecast to grow its bottom line by 9% in each of the next two years, while its yield of 4.9% is not only highly attractive, it is also set to increase at a brisk pace. That’s because dividend per share growth is expected to be as much as 7.5% next year, meaning shares in HSBC could be yielding 5.3% next year (assuming the share price does not change from its present level). Furthermore, HSBC is well positioned to benefit from a pickup in the macroeconomic outlook for emerging markets and, as a result, could deliver improved growth prospects going forward.

BHP Billiton

Despite experiencing a number of highly challenging years, BHP Billiton (LSE: BLT) has weathered the storm better than many of its mining peers. That’s due to its vast diversification, as well as a sound strategy of mothballing large projects until they become more economically attractive. With the outlook for China continuing to improve, BHP Billiton is well placed to benefit from buoyant demand, while a yield of 3.6% is highly impressive for a mining stock with strong long term growth potential.


Shares in easyJet (LSE: EZJ) have been hit by the recent spike in the oil price, as well as disappointment among many investors regarding its profit forecasts. However, easyJet continues to offer growth potential that is superior to that of the wider market, with earnings per share (EPS) expected to increase by 12% in each of the next two years. Combined with a P/E of just 11.7, this makes easyJet’s price to earnings growth (PEG) ratio less than 1, which is highly attractive. In addition, a yield of 2.9% looks set to grow at a brisk pace, as dividends per share are expected to be 12.5% higher next year than this year.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Peter Stephens owns shares of BHP Billiton, GlaxoSmithKline and HSBC Holdings. The Motley Fool recommends GlaxoSmithKline.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.